4//SEC Filing
Tokman Alexander Y 4
Accession 0001209191-22-000961
CIK 0001681682other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 5:07 PM ET
Size
5.4 KB
Accession
0001209191-22-000961
Insider Transaction Report
Form 4
Tokman Alexander Y
DirectorChief Executive Officer
Transactions
- Award
Stock Options
2022-01-03+12,000→ 12,000 totalExercise: $0.74From: 2023-01-03Exp: 2032-01-03→ Common Stock (12,000 underlying)
Footnotes (1)
- [F1]Represents a stock option award granted on January 3, 2022 pursuant to the Issuer's Non-Employee Director Compensation Policy.
Documents
Issuer
ENDRA Life Sciences Inc.
CIK 0001681682
Entity typeother
Related Parties
1- filerCIK 0001334483
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 5:07 PM ET
- Size
- 5.4 KB